2014
DOI: 10.6004/jnccn.2014.0156
|View full text |Cite
|
Sign up to set email alerts
|

Role of MRI in Primary Brain Tumor Evaluation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
22
0
11

Year Published

2015
2015
2024
2024

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 34 publications
(33 citation statements)
references
References 55 publications
0
22
0
11
Order By: Relevance
“…MRI is used extensively to characterize tumors, due to its high soft-tissue contrast and superior image resolution. Beyond T1- and T2-weighted measurements of changes in tumor volume (Jost et al , 2007; Leung et al , 2014; Ellingson et al , 2015), a number of different MR-based methods have been examined for evaluating treatment response, including diffusion imaging (Farjam et al , 2014; Moffat et al , 2006; Tsien et al , 2014), perfusion imaging (Hakyemez et al , 2005; Law et al , 2008), and MR spectroscopy (Horska and Barker, 2010; Kumar et al , 2015). Although these techniques have shown promise for detecting and characterizing recurrent tumors after radiation treatment, none represent current standard of care for assessing treatment response.…”
Section: Introductionmentioning
confidence: 99%
“…MRI is used extensively to characterize tumors, due to its high soft-tissue contrast and superior image resolution. Beyond T1- and T2-weighted measurements of changes in tumor volume (Jost et al , 2007; Leung et al , 2014; Ellingson et al , 2015), a number of different MR-based methods have been examined for evaluating treatment response, including diffusion imaging (Farjam et al , 2014; Moffat et al , 2006; Tsien et al , 2014), perfusion imaging (Hakyemez et al , 2005; Law et al , 2008), and MR spectroscopy (Horska and Barker, 2010; Kumar et al , 2015). Although these techniques have shown promise for detecting and characterizing recurrent tumors after radiation treatment, none represent current standard of care for assessing treatment response.…”
Section: Introductionmentioning
confidence: 99%
“…14 For these WHO-classified grade-II diffuse gliomas without disruption of the blood-brain barrier and contrast enhancement, the FLAIR sequence is recommended by the American National Comprehensive Cancer Network because it can provide the best delineation and volumetric measurements of the tumor in region of interest (ROI) placement or intraoperative navigation. 15,16 Also, T 2 FLAIR images provide a measure of free water and eliminate the signal from cerebrospinal fluid, which may help improve the diagnostic precision of lesions in the cortical/subcortical areas that oligodendrogliomas are frequently located in. 8,17 Therefore, T 2 FLAIR images, as a scanning sequence used routinely in institution, were selected to analyze texture features in the present study.…”
mentioning
confidence: 99%
“…MRI is the recommended modality for evaluation of the brain tissues due to its superior resolution compared to CT scanning [16]. Fusion of diagnostic MRIs to RT planning CTs is a widely used method for accurate target delineation in various cancers, and it is most emphasized for brain tumors [5][6][7].…”
Section: Discussionmentioning
confidence: 99%